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Bioactivation and Covalent Binding of
Halothane to Liver Macromolecules
by 1. Glenn Sipes,* Thomas L. Podolsky,*
and Burnell R. Brown, Jr.*
In this manuscript we report our attempts todetermine if I4C-halothane or its metabolites interact with
DNA. Three bioactivation systems were used: in vitro microsomal incubations, isolated hepatocytes, and
in vivo administration. Even though we used optimal conditions for bioactivation, no significant covalent
binding of 14C to DNA was observed. Slight 14C activity above background (6 dpm/O.1 mg DNA) was
observed in the microsomal incubations but is considered insignificant because it was not reduced when
NADPH was omitted from the incubations. We were able to demonstrate covalent binding to nuclear
lipids and proteins when rats were pretreated with phenobarbital and maintained in a hypoxic environ-
ment (14%02). Similarly, these conditions markedly increased covalent binding of 14C from 14C-
-halothane to microsomal proteins and lipids. Isolated rat hepatocytes proved to be a viable system for
studying the bioactivation of halothane. In this system it was also possible to demonstrate increased
binding under N2 and/or phenobarbital pretreatment.
Introduction
In recent years, attention has been focused on the
activation of relatively inert chemicals by liver mi-
crosomal enzymes during the process of biotrans-
formation or drug metabolism (1, 2). The products
of this "bioactivation" ofdrugs and other xenobiot-
ics are reactive intermediates, species possessing a
chemical reactivity that is greater than that of the
parent compound or its urinary, biliary, or fecal
metabolites. These reactive intermediates can co-
valently interact with tissue macromolecules such as
proteins, lipids and nucleic acids and thus alter
cellular integrity (1, 2). Reactive intermediates
from such diverse compounds as carbon tetrachlo-
ride (3), chloroform (4), bromobenzene (5, 6),
acetaminophen (7, 8), and furosemide (9) as well as
others have been implicated as the causative agents
in the hepatotoxicity associated with administration
of these compounds. Similarly, the production of
hepatic neoplasms by chronic exposure to di-
methylnitrosamine (10), N-acetylaminofluorene
(11), vinyl chloride (12) and trichloroethylene (13) is
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thought to result from endogenously produced
reactive intermediates.
Halothane (1,1,1-trifluoro-2-bromo-2-chloro-
ethane) undergoes biotransformation in man (14,
15) and laboratory animals (16) and metabolites
(reactive intermediates) of halothane have been
shown to covalently bind to liver proteins and
lipids in the rat (17-20). The isolation from
human urine of N-trifluoroacetyl-2-aminoeth-
anol and N-acetyl-S-(2, bromo-2-chloro-1,
l-difluoroethyl-L-cysteine) by Cohen et al. (15)
strongly suggests that halothane is also bioactivated
by man. The production of reactive intermediates
may explain the rare, unpredictable and sporadic
cases of hepatic failure following anesthesia with
halothane (21). Certain individuals may produce an
abnormally high amount of reactive intermediates
that may overwhelm detoxification mechanisms.
The production of reactive intermediates by man
also raises concern about the chronic exposure of
anesthesiologists and other operating room person-
nel to trace concentrations of halothane and other
anesthetic gases. Indeed, numerous epidemiologi-
cal studies have reported a higher incidence of
spontaneous abortions, congenital abnormalities,
liver disease and various malignancies in anes-
thesiologists and operating room personnel as com-
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cal and nursing professionals (22). The structural
similarity of halothane and some of its known
metabolites to such carcinogens as vinyl chloride,
vinylidene chloride, and trichloroethylene under-
scores the concern about anesthetics and cancer
(13).
One of the suggested mechanisms of chemical
carcinogenesis is the somatic mutation theory
whereby a heritable change in nucleotide sequence
results from an alteration in the primary structure of
DNA (24). Nearly all known chemical carcinogens
covalently bind to DNA. Ifthis altered DNA is not
repaired or is subject to error prone repair, then a
heritable change in nucleotide sequence can occur
(24). Repeated insult to DNA by chronic exposure
to carcinogens may result in a number of mutations
that ultimately leads to invasive cells.
The reported cases of halothane-induced
hepatitis following anesthesia and the epidemiologi-
cal studies correlating an increased cancer risk with
chronic exposure to inhalation anesthetics prompted
us to study the covalent binding of halothane to
liver macromolecules, with particular emphasis on
binding to DNA. We report significant binding of
14C from 14C-halothane to liver proteins and phos-
pholipids, particularly under hypoxic conditions.
However, no binding to DNA or RNA was ob-
served when halothane was administered in Oi'Ao or
added to microsomal incubations or isolated liver
cells.
Materials and Methods
Animals and Pretreatments
Male Sprague-Dawley rats, 150-250 g, were ob-
tained from Hilltop Laboratories and fed Purina rat
chow and water ad libitium. For induction of the
microsomal enzymes animals were pretreated in-
traperitoneally with either Aroclor 1254 (a poly-
chlorinated biphenyl containing 54% Cl) at a single
dose of 500 mg/kg in sesame oil 120 hr prior to sac-
rifice or phenobarbital (80 mg/kg) in normal saline
for four consecutive daily doses beginning 5 days
before sacrifice. Control rats received an appro-
priate volume of solvent (sesame oil or normal
saline).
Covalent Binding Studies
Microsomal incubations were performed as pre-
viously described (19, 25). Briefly, microsomes
were isolated by differential centrifugation (9000 g
for 20 min; 105,000 g for 60 min) from liver
homogenized in cold Tris-KCI buffer (0.OSM Tris,
1.15% KCI, pH 7.4). After the first sedimentation of
the microsomal pellet, the microsomes were
washed with Tris-KCI buffer by rehomogenization
followed by recentrifugation at 105,000 g and then
frozen overnight at -700C.
For incubation with 14C-halothane the micro-
somes were resuspended in Tris-KCI buffer and
adjusted to the desired protein concentration as
determined by the Biuret procedure (26). Each in-
cubation vial contained the following in a final vol-
ume of 2.5 ml: 2-8 mg/ml microsomal protein; 14C-
halothane dissolved in ethanol (0.125-1.OmM);
specific activity 1.5-3.7 mCi/mmole); 0.13mM
NADPH; 0.07 mM NADP; 1.16mM glucose-
6-phosphate; 2 I.E.U. glucose-6-phosphate dehy-
drogenase, 50mM Tris; 2.3mM MgCl2 and 2.9 mg
KCI at a final pH of 7.4. Certain incubation vials
contained 2 mg/2.5 ml calf thymus DNA (Cal-
biochem).
Incubations were performed in closed 20-ml flasks
at370C forthe desired time (usually 30 min) underair
or N2. Samples containing heat denatured micro-
somes or no NADPH were run concurrently to de-
termine nonenzymatically bound radiolabel. At the
end ofincubation, a 1.0 ml aliquot was removed and
added to 5 ml of CHC13: methanol (3:1) to extract
phospholipids.
To remove noncovalently bound radiolabel, the
CHC13-methanol extracts were washed three times
with equal volumes ofTris-KCl buffer and then with
water to extract polar metabolites. The CHC13x
methanol was then evaporated at 60°C with N2.
This evaporation procedure was repeated with
CHC13 (5 ml x 3) and with halothane (2 ml x 2) to
remove any '4C-halothane or volatile metabolites.
Since Van Dyke (17)-reported the lipid binding to be
associated primarily with phospholipids, binding to
the lipid fraction is expressed in terms ofphosphorus
as determined by the procedure ofDittmerand Wells
(29). The radioactivity in the lipid fraction as well as
in the protein, RNA and DNA was determined by
liquid scintillation counting, Aquasol being used as
the scintillation cocktail.
To the remaining incubate was added 4 ml of 6%
p-aminosalicylic acid-I% NaCl to aid in the separa-
tion of nucleic acids from protein. Three phenol ex-
tractions [procedure of Kirby (27)] were used to
separate RNA and DNA from protein. Protein was
precipitated from phenol extracts by using two vol-
umes of methanol. The isolated proteins were sub-
jected to numerous solvent extractions (25) to re-
move noncovalently bound radiolabel. The repeated
ethanol, ethoxyethanol, and ethanol-cresol precipi-
tations ofnucleic acids were sufficient to remove any
radiolabel. RNA and DNA were separated by the
selective alkaline hydrolysis of RNA followed by
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tion of DNA, RNA, and protein, the procedures of
Burton £30). Ceriotti £31), and Lowry (32) were used
respectively.
Isolated rat hepatocytes were obtained by the col-
lagenase procedure of Hayes and Brendel which is
described in detail elsewhere (33). The twice-washed
cells were resuspended in Waymouth's Hepes
medium at a concentration of40 mg/ml (wet weight),
and then 5-ml aliquots were added to 50-ml incu-
bation flasks with raised conical bottoms. 14C-
Halothane was added toeach incubationflask, which
was then capped with aground glass stopper and the
reactions performed at 37°C in a gyrating incubator.
At the end of incubation, the cells were pooled,
homogenized with aglass on glass homogenizer, and
subjected to differential centrifugation forisolation of
the microsomal fraction. From this fraction mic-
rosomal phospholipids were isolated as described
above, while proteins were precipitated from the
Tris-KCl resuspended microsomes by 10%
trichloroacetic acid (TCA). Both fractions were ex-
tensively extracted with various solvents as for mi-
crosomal incubations.
In the in vivo experiments, phenobarbital-
pretreated and control rats were placed in a 25-liter
Plexiglas chamber and exposed to a hypoxic envi-
ronment (86% N2, 14% 02) for 60 min prior to the
intraperitoneal injection of 14C-halothane (88
pACi/kg, 3.7mCi/mmole), and then immediately re-
turned to the hypoxic environment for 2 hr. Simi-
larly, induced and control rats were injected with
I4C-halothane but maintained in room air. At the
end of 2 hr the animals were sacrificed and the liv-
ers removed and divided into three sections of 2 g
each. These sections were used for (1) isolation of
DNA and RNA by the Kirby procedure; (2) isola-
tion ofmicrosomal proteins and lipids, and (3) isola-
tion of intact nuclei (34). From the intact nuclei
phospholipids were extracted as above and proteins
were isolated by precipitation with 10% TCA.
Results
Figures 1-4 summarize the results ofour initial in
vitro microsomal studies that were conducted to es-
tablish the effects oftime ofincubation, microsomal
protein concentration, and halothane concentration
on the covalent binding ofhalothane to microsomal
protein and lipids. Since we had previously re-
ported that pretreatment of rats with Aroclor 1254
greatly enhanced covalent binding (19), our plans
were to use microsomes from Aroclor
1254-pretreated rats in investigating the possible in-
teraction of reactive intermediates of halothane
with DNA. However, subsequent studies revealed
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FIGURE 1. Time curve for the in vitro covalent binding of
14C-halothane to microsomal phospholipids. Incubations con-
tained 0.3mM 14C-halothane, 4 mg/ml microsomal protein
and a NADPH generating system. N2 indicates vials were
flushed for 5 min with 100% N2 to approach anaerobic condi-
tions. Aroclor 1254 indicates microsomes were obtained from
rats pretreated with 500 mg/kg Aroclor 1254 (IP).
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FIGURE 2. Effects of microsomal protein concentration on co-
valent binding of '4C-halothane to microsomal lipids and pro-
tein. Incubations performed in air. Other conditions as in
Figure 1.
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FIGURE 3. Effect of halothane concentration on the in vitro
covalent binding of 14C-halothane to microsomal lipids. Con-
ditions as in Figure 1.
that Aroclor 1254 pretreatment greatly reduced the
yield of nuclei from whole liver and from isolated
hepatocytes. Since this was not the case with
phenobarbital pretreatment, the in vivo and isolated
hepatocytes studies were conducted in phenobarbi-
tal and control rats. Both inducing agents were used
for the microsomal incubations.
The two most important points to be gained from
the data in Figures 1-4 are that microsomal induc-
tion increases covalent binding of halothane
metabolites to both lipids and proteins and that a
reduced 02 tension, incubation under N2, greatly
enhances this binding to induced as well as control
microsomes. Although only the data for Aroclor
1254 pretreatment is presented, microsomes from
phenobarbital treated rats displayed an enhanced
binding of similar magnitude. We are confident that
covalent binding is related to metabolism, since
omission of NADPH or heat denaturation of mi-
crosomes severely reduces binding. However, it
FIGURE 4. Effect of halothane concentration on the in vitro
covalent binding of '4C-halothane to microsomal protein.
Conditions as in Figure 1.
should be emphasized that there was always a low
level ofbinding in these blanks which was routinely
subtracted. It can become significant at low con-
centrations ofmicrosomal protein and short incuba-
tion periods (1-5 min).
From these initial studies, it was decided to incu-
bate microsomes with calfthymus DNA for 30 min
at a protein concentration of 4 mg/ml and a final
halothane concentration of O.1mM. This low con-
centration ofhalothane was chosen to avoid diluting
the specific activity of the 14C-halothane. At low
specific activities any spurious radioactivity as-
sociated with DNA calculates as a high and mis-
leading number ofpicomoles of 14C bound to DNA.
The data in Table 1 summarize the results offour
separate microsomal incubations that were per-
formed to determine whether or not metabolites of
halothane were covalently bound to calf thymus
DNA. The 14C activity associated with the DNA
fraction was always less than 6 dpm/0. mg DNA.
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174Table 1. In vitro covalent binding of 14C from '4C-halothane to microsomal proteins and lipids.a
"4C from 14C from 14C from
microsomal microsomal calfthymus
proteins, pmole/mg lipids, pmole/t,mole DNA, pmole/mg DNAb
Pretreatment N2 Air N2 Air N2 Air
Phenobarbital 346 ± 19 115 ±25 1035 19 586 ± 48 7 4 5 I
Aroclor 1254 320 ± 38 75 ±16 1040 40 290 ± 34 10 2 5 I
Control 65 ± 6 28 ± 3 272 46 75 + 25 9 3 8 3
"Incubations contained 0. l1mM halothane. For the protein and lipids, background binding was determined by omission of
NADPH and has been subtracted from the above values.
"The DNA values represent radioactivity associated with the isolated and extracted DNA and represent calculations
from 6 dpm above background or less. The level ofradioactivity associated with the DNA was not reduced by omission of
NADPH and probably represents trace contamination rather than covalent binding.
There was no difference in DNA associated
radioactivity when incubations were performed
with or without the addition of NADPH or when
induced microsomes were used. The binding to
DNA as opposed to that of microsomal lipids or
protein, is presented without subtraction of back-
ground counts (i.e., samples without NADPH) for
comparison of DNA with lipids and proteins. The
binding to protein and lipids was always studied to
insure that the microsomal system was active and
induced. These studies complement those pre-
sented in Figures 1-4, in that microsomal induction
and incubation under N2 enhance the binding to
microsomal proteins and lipids. The quantity of
radioactivity associated with microsomal RNA was
similar to that associated with the DNA. Very few
counts (< 10 dpm above background) were ob-
served in the RNA fraction obtained by alkaline
hydrolysis of the precipitated nucleic acids.
After some experimentation, the isolated hepato-
cytes proved to be a viable system for studying the
bioactivation of halothane. In fact, for a 30 min in-
cubation, it was possible to demonstrate enhanced
covalent binding of halothane metabolites to both
microsomal and nonmicrosomal lipids and proteins
when the cells and 14C-halothane were incubated
under N2 (Table 2). The covalent binding to pro-
teins and lipids was greater in the cells obtained
from phenobarbital induced animals. This en-
hancement was particularly evident in the micro-
somal fraction when the cells were incubated in air.
In the study presented in Table 2. NADPH was
added to the incubating cells to aid biotransforma-
tion since it may leak out of freshly isolated cells.
Also Weddle et al. (35) reported that addition of
NADPH enhanced CCI ,-induced lipoperoxidation
in isolated hepatocytes.
We have only been partially successful in extract-
ing DNA from isolated cells. The yield of DNA
that is recovered is only about one-tenth the yield
that would be expected on the basis of weight of
liver. However, no radioactivity was present in the
DNA or RNA that was obtained from the cells
incubated with '4C-halothane.
Table 3 summarizes our results to date on the in
vivo covalent binding of metabolites of halothane to
liver microsomal and nuclear macromolecules.
Phenobarbital pretreatment resulted in a marked
increase in covalent binding to microsomal proteins
and lipids. This enhanced binding was most evident
when the rats were maintained at 14% 0., rather
than atmospheric conditions (21% 02).
Perhaps the most interesting observation was the
tremendous increase in the binding to nuclear lipids
in phenobarbital-pretreated animals maintained
under hypoxic conditions. Although the radioactiv-
ity associated with this fraction was 80 dpm above
background, the low level of nuclear phospholipids
as compared to microsomal phospholipids inflates
the value when binding is expressed as pico-
moles/,umole. The binding to nuclear protein in
phenobarbital-pretreated hypoxic rats represents
Table 2. In vitro covalent binding of 14C from '4C-halothane to isolated rat liver cells."
4C from protein, pmole/mg protein 14C from lipids. pmole/4Lmole lipid P
Air N2 Air N2
Phenobarbital-treated
Microsomal 96 182 379 817
Nonmicrosomal 12 75 77 678
Control cells
Microsomal 13 60 43 446
Nonmicrosomal 5 23 32 281
*Incubations were for 30 min under air or N2, at a final concentration of0.06/nM halothane. Each value represents the
mean of two separate incubations.
December 1977 175Table 3. In vivo covalent binding of 14C from "4C-halothane to rat liver macromolecules.a
Phenobarbital-
pretreated rats Control rats
Air 14% 02"b Air 14% 02 '
'4C from microsomal protein, 20 80 8 22
pmole/mg protein
14C from microsomal lipids, 32 180 7 20
pmole/,umole lipid P
14C from nuclear proteins, 3' 12 3' 3'
pmole/mg protein
4C from nuclear lipids, 12' 229 8' 9'
pmole/,umole lipid P
14C from nucleic acids, None None
pmole/mg
"Each value represents the mean of two animals. Rats received 88 ,Ci/kg of '4C-halothane intraperitoneally and were
sacrificed after 2 hr.
'These animals were maintained at 14% 02/86% N2 for I hr prior to and after administration of halothane.
'Thesevalues werecalculatedfromlessthan 10dpmabovebackground. Noradioactivity wasdetectedinRNAorDNAas
isolated by the Kirby procedure.
about 50 dpm above background, but the binding
appears much lower than to lipids due to the higher
yield of nuclear protein.
No covalent binding of halothane or its metabo-
lites to RNA or DNA was observed. In fact, no
radioactivity was recovered in the purified DNA or
RNA fractions.
Discussion
The primary objective ofthis study was to deter-
mine whether halothane or its metabolites cova-
lently interact with DNA. Three separate
bioactivation systems were used to answer this
question: liver microsomal incubations, incubation
with isolated hepatocytes, and in viwo ad-
ministration. Procedures known to enhance the
biotransformation and covalent binding of
halothane to lipids and protein, microsomal enzyme
induction, and hypoxia, were also used to optimize
favorable conditions for bioactivation.
In only one system, microsomal incubation, was
radioactivity observed in the isolated and purified
DNA. However, these data are highly suspect be-
cause the level of radioactivity was only 6 dpm or
less above background and omission of NADPH
from the incubations did not decrease binding.
Therefore, it is unlikely that the radioactivity as-
sociated with calf thymus DNA represents true
covalent binding of a reactive intermediate of
halothane to DNA. This radioactivity may rep-
resent a failure to extract halothane, one of its
metabolites, or a contaminant in the 14C-halothane
completely from the DNA fraction, or alternately,
contamination of DNA with traces of protein.
However, it should also be emphasized that ifbind-
ing does occur to DNA, one would expect it to be
extremely low. Also, it is possible that a relatively
minor NADPH-independent pathway for bioacti-
vation of halothane may be present in the micro-
somal fraction.
As stated, the microsomal incubations were per-
formed to optimize bioactivation and binding con-
ditions. This is a highly nonphysiological system,
since the endoplasmic reticulum and DNA are
never in such intimate contact. Therefore, when no
significant binding was found in this system, it is not
surprising that binding to DNA was not observed in
isolated hepatocytes or whole animal studies. Rao
(20) also failed to observe covalent binding of
halothane to DNA when administered intra-
peritoneally to phenobarbital treated rats. In addi-
tion, Baden et al. (36) reported that halothane was
not mutagenic to Salmonella typhimurium when the
bacteria and halothane were incubated with liver
homogenates (900 g supernatant).
Of particular interest in the binding of halothane
metabolite(s) to nuclear proteins and lipids, which
became evident in the phenobarbital pretreated rats
subjected to hypoxia. Since certain nuclear proteins
are involved in DNA synthesis and repair, any al-
teration in their structure or activity may reduce the
fidelity of DNA replication or alter the normal
transcription process. Additional studies are being
done to confirm these preliminary results. Also,
studies with isolated nuclei should be performed,
since it is known that nuclei can bioactivate certain
xenobiotics (37).
We were able to confirm previous reports that
microsomal enzyme induction and/or incubation
under reduced oxygen tension enhances the in vitro
covalent binding of halothane metabolites to mi-
crosomal protein and lipids (17, 18, 38, 39). In addi-
tion we were able to demonstrate enhanced co-
valent binding in isolated hepatocytes when the
cells were isolated from phenobarbital-pretreated
rats or incubated under N2.
In 1976 Widger et al. (18) reported that there was
Environmental Health Perspectives 176a significant increase in the in vivo covalent binding
ofhalothane metabolites to microsomal protein and
lipids when phenobarbital treated rats were sub-
jected to reduced oxygen tension and exposed to
14C-halothane via inhalation. Similar results were
obtained in this study when the 14C-halothane was
administered intraperitoneally. These findings are
oftoxicological significance since it is now possible
to consistently induce extensive centrilobular liver
necrosis by halothane anesthesia (1%) in phenobar-
bital pretreated rats maintained at 14% 02 and 85%
N20 or N2 (40, 41).
In conclusion it is suggested that a continued ef-
fort be directed towards firmly establishing whether
or not halothane or certain of its metabolites can
interact with DNA. The only rational approach is
to conduct similar studies with 1'C-halothane of
much higher specific activity than currently availa-
ble. This will permit the administration of higher
doses as well as more radioactivity. In addition,
attention should also be directed to the nature of
halothane metabolites with nuclear proteins and
lipids.
This study was supported by USPHS Grant IROI CA
21820-01.
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